The finding that hGC33-null-NP significantly inhibited GPC3-positive hepatoma cells showed that the inhibitory effect of PEG-b-PLGA NP surface-modified hGC33 on HCC cell proliferation depends on the expression of GPC3 antigen on the cell surface. Here, GPC3 is linked to hepatocellular carcinoma.